Novel ghrelin analogs designed for anti-obesity applications include receptor antagonists, inverse agonists, and modified peptides targeting specific ghrelin functions — the drug design landscape for ghrelin-based weight management.
Key findingNovel ghrelin analogs designed for anti-obesity applications include receptor antagonists, inverse agonists, and modified peptides targeting specific
What the researchers found
Novel ghrelin analogs designed for anti-obesity applications include receptor antagonists, inverse agonists, and modified peptides targeting specific ghrelin functions — the drug design landscape for ghrelin-based weight management.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2009.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Ghrelin--a novel generation of anti-obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues.
Journal of peptide science : an official publication of the European Peptide Society, 15(11), 711-30
Citation
Chollet, Constance; Meyer, Karolin; Beck-Sickinger, Annette G. (2009). Ghrelin--a novel generation of anti-obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues.. Journal of peptide science : an official publication of the European Peptide Society, 15(11), 711-30. https://doi.org/10.1002/psc.1177